Johnson & Johnson COVID-19 vaccine trial to resume

[KMSP-TV Fox 9 News, October 23, 2020] As the amount of COVID-19 cases continues to rise across the country, the pressure is on to develop a vaccine, but health experts say development should not be rushed.

Dr. Frank Rhame of Allina Health is part of the Johnson & Johnson COVID-19 vaccine trial which was paused October 12 when a participant got sick. Rhame said he learned Friday, the person’s illness was determined to be unrelated to the vaccine and the study will resume.

Posted on October 23, 2020 in coronavirus, Infectious Disease